Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 62 | 26 | 40 | 69 | 28 |
| Cost of Goods | 2,104 | 2,213 | 2,387 | 2,321 | 2,094 |
| Gross Profit | -2,042 | -2,187 | -2,347 | -2,252 | -2,066 |
| Operating Expenses | 3,876 | 3,930 | 10,687 | 3,379 | 3,721 |
| Operating Income | -5,814 | -5,904 | -12,647 | -5,310 | -5,693 |
| Interest Expense | 0 | 0 | 0 | 140 | 197 |
| Other Income | -8,818 | 1,338 | -8,898 | 16,439 | -3,225 |
| Pre-tax Income | -14,632 | -4,566 | -21,545 | 10,989 | -9,115 |
| Net Income Continuous | -14,632 | -4,566 | -21,545 | 10,989 | -9,115 |
| Net Income Discontinuous | -5 | -4 | 14 | 448 | 1 |
| Minority Interests | N/A | N/A | N/A | 4 | 9 |
| Net Income | $-14,637 | $-4,570 | $-21,531 | $11,433 | $-9,123 |
| EPS Basic Total Ops | -9.45 | -2.55 | -13.35 | 43.35 | -35.25 |
| EPS Basic Continuous Ops | -9.45 | -2.55 | -13.42 | 41.66 | -35.25 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.01 | 1.70 | 0.00 |
| EPS Diluted Total Ops | -9.45 | -2.70 | -13.35 | -19.05 | -35.25 |
| EPS Diluted Continuous Ops | -9.45 | -2.70 | -13.42 | 41.66 | -35.25 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.01 | 1.70 | 0.00 |
| EBITDA(a) | $-5,584 | $-5,678 | $-12,396 | $-5,089 | $-5,489 |